Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic eosinophilic leukemia].

I Kredzielak-Manikowska1, Z Traczyk, B Ceglarek

  • 1Klinika Chorób Wewnetrznych.

Polskie Archiwum Medycyny Wewnetrznej
|March 10, 2001
PubMed
Summary

This case study details a 24-year-old male with chronic myelogenous eosinophilic leukemia (pbe) who transformed into myeloblastic crisis. Successful treatment involved chemotherapy and allogeneic bone marrow transplantation, leading to remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing service usage and protective factors in a pediatric psychiatry clinic during the COVID-19 pandemic.

Frontiers in psychology·2024
Same author

A confirmed association between DNA variants in CAPN9, OSM, and ITGAM candidate genes and the risk of umbilical hernia in pigs.

Animal genetics·2023
Same author

Extent of the frontal sinuses in the aspect of neurosurgical craniotomy approaches.

Folia morphologica·2021
Same author

Comorbidity of bipolar I disorder and conduct disorder: a familial risk analysis.

Acta psychiatrica Scandinavica·2019
Same author

Pediatric mania: a developmental subtype of bipolar disorder?

Acta neuropsychiatrica·2016
Same author

Germline gene polymorphisms predisposing domestic mammals to carcinogenesis.

Veterinary and comparative oncology·2015

Area of Science:

  • Hematology
  • Oncology

Background:

  • Chronic myelogenous eosinophilic leukemia (pbe) is a rare hematologic malignancy.
  • Transformation into myeloblastic crisis presents a significant clinical challenge.

Observation:

  • A 24-year-old male presented with leukocytosis, eosinophilia, splenomegaly, anemia, and thrombocytopenia.
  • The patient progressed to myeloblastic crisis despite negative cytogenetic and BCR/ABL tests.
  • Blastic acceleration was confirmed by flow cytometry, showing eosinophil dominance.

Findings:

  • Induction chemotherapy (Hydroxyurea, Cytarabine, Doxorubicin) and spleen irradiation achieved complete remission.
  • Allogeneic bone marrow transplantation (allo-BMT) from a related donor was performed.
  • An 18-month follow-up showed no disease relapse after allo-BMT.

Related Experiment Videos

Implications:

  • This case highlights a successful treatment strategy for a rare leukemia transformation.
  • Chemotherapy followed by allo-BMT can be effective in managing myeloblastic crisis in pbe.
  • Effective management of pbe transformation underscores the importance of timely and aggressive therapeutic interventions.